Geron | GERN - La Marge Brute Sur Les Ventes





La Marge Brute Sur Les Ventes Changement Date
Amgen USD 6.89B 415M 2025-12
Bio Techne USD 208.29M 17.01M 2026-03
Cassava Sciences USD -3.96M 1.16M 2025-09
Cytokinetics USD 19.2M 1.44M 2026-03
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Exelixis USD 590.86M 18.68M 2026-03
Genmab DKK 977M 13M 2025-12
Geron USD 50.14M 3.44M 2026-03
Gilead Sciences USD 5.52B 791M 2026-03
Incyte USD 1.17B 217.51M 2026-03
MacroGenics USD 31.11M 30.14M 2025-12
Novartis USD 10.07B 184M 2026-03
Novavax USD 125.04M 76.09M 2025-12